Becker G - Search Results

1

Screening for mutations of the IRP2 gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

Deplazes J, Schöbel K, Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Becker G, Riess O, Berg D. Deplazes J, et al. Among authors: becker g. J Neural Transm (Vienna). 2004 Apr;111(4):515-21. doi: 10.1007/s00702-004-0125-z. J Neural Transm (Vienna). 2004. PMID: 15057521

2

Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

Felletschin B, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Sommer U, Zeiler B, Becker G, Riess O, Berg D. Felletschin B, et al. Among authors: becker g. Neurosci Lett. 2003 Nov 27;352(1):53-6. doi: 10.1016/j.neulet.2003.08.026. Neurosci Lett. 2003. PMID: 14615048

3

Echogenic substantia nigra in patients with orthostatic tremor.

Spiegel J, Behnke S, Fuss G, Becker G, Dillmann U. Spiegel J, et al. Among authors: becker g. J Neural Transm (Vienna). 2005 Jul;112(7):915-20. doi: 10.1007/s00702-004-0236-6. Epub 2004 Nov 3. J Neural Transm (Vienna). 2005. PMID: 15526141

4

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Zeiler B, Bornemann A, Pahnke J, Becker G, Riess O, Berg D. Hochstrasser H, et al. Among authors: becker g. Neurology. 2004 Nov 23;63(10):1912-7. doi: 10.1212/01.wnl.0000144276.29988.c3. Neurology. 2004. PMID: 15557511

5

Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease.

Berg D, Merz B, Reiners K, Naumann M, Becker G. Berg D, et al. Among authors: becker g. Mov Disord. 2005 Mar;20(3):383-5. doi: 10.1002/mds.20311. Mov Disord. 2005. PMID: 15486999

6

Functional relevance of ceruloplasmin mutations in Parkinson's disease.

Hochstrasser H, Tomiuk J, Walter U, Behnke S, Spiegel J, Krüger R, Becker G, Riess O, Berg D. Hochstrasser H, et al. Among authors: becker g. FASEB J. 2005 Nov;19(13):1851-3. doi: 10.1096/fj.04-3486fje. Epub 2005 Sep 8. FASEB J. 2005. PMID: 16150804

7

Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica.

Berg D, Becker G, Reiners K. Berg D, et al. Among authors: becker g. J Neural Transm (Vienna). 1999;106(7-8):725-8. doi: 10.1007/s007020050192. J Neural Transm (Vienna). 1999. PMID: 10907730

8

Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients.

Wintermeyer P, Krüger R, Kuhn W, Müller T, Woitalla D, Berg D, Becker G, Leroy E, Polymeropoulos M, Berger K, Przuntek H, Schöls L, Epplen JT, Riess O. Wintermeyer P, et al. Among authors: becker g. Neuroreport. 2000 Jul 14;11(10):2079-82. doi: 10.1097/00001756-200007140-00004. Neuroreport. 2000. PMID: 10923647

9

Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound.

Becker G, Berg D. Becker G, et al. Mov Disord. 2001 Jan;16(1):23-32. doi: 10.1002/1531-8257(200101)16:1<23::aid-mds1003>3.0.co;2-2. Mov Disord. 2001. PMID: 11215589 Review.

10

Does ultrasound disclose a vulnerability factor for Parkinson's disease?

Behnke S, Berg D, Becker G. Behnke S, et al. Among authors: becker g. J Neurol. 2003 Feb;250 Suppl 1:I24-7. doi: 10.1007/s00415-003-1104-0. J Neurol. 2003. PMID: 12761631 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,660 results

Search Page

Filters